Carmine Rossi

8PUBLICATIONS
12CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 25, 2026
Real-world comparative effectiveness of apalutamide versus enzalutamide for prostate-specific antigen response in metastatic castration-sensitive prostate cancer.

|Nov 21, 2025
Real-World Comparison of On-Label Treatment Persistence Through 24 Months Between Patients with Psoriatic Arthritis Initiating Guselkumab or Subcutaneous Interleukin-17A Inhibitors.

Philip J Mease, Jessica A Walsh, Timothy P Fitzgerald

|Nov 01, 2024
Comparison of Time to Next Treatment or Death Between Front-Line Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Bortezomib, Lenalidomide, and Dexamethasone (VRd) Among Transplant-Ineligible Patients With Multiple Myeloma.

Doris K Hansen, Santosh Gautam, Marie-Hélène Lafeuille

|Sep 20, 2024
Real-World Outcomes of First-Line Treatment With Anti-PD(L)1-Based Combination Therapy for Nonsquamous Metastatic Non-Small Cell Lung Cancer: A Multiregional Chart Review in Europe, Japan, and the United States.

Stephen V Liu, Anandaroop Dasgupta, Dominick Latremouille-Viau

|Jul 31, 2024
Treatment patterns for patients with BRCA1/2-positive metastatic castration-resistant prostate cancer.

Mehmet A Bilen, Ibrahim Khilfeh, Carmine Rossi

|Mar 14, 2024
Real-World Treatment Patterns and Clinical Outcomes After Platinum-Doublet Chemotherapy and Immunotherapy in Metastatic Non-Small Cell Lung Cancer: A Multiregional Chart Review in the United States, Europe, and Japan.

Ticiana A Leal, Anandaroop Dasgupta, Dominick Latremouille-Viau

Pageof 2

Frequent Collaborators

2 joint publications

Bruno Emond

2 joint publications

Ticiana A Leal

2 joint publications

Dominick Latremouille-Viau

2 joint publications

Pragya Rai